title: Cytochrome c release is required for phosphatidylserine peroxidation during Fas-triggered apoptosis in lung epithelial A549 cells.
abstract: Oxidation of phosphatidylserine (PtdSer) has been shown to play a pivotal role in signaling during cell apoptosis and subsequent recognition of apoptotic cells by phagocytes. However, the redox catalytic mechanisms involved in selective PtdSer oxidation during apoptosis remain poorly understood. Here we employed anti-Fas antibody CH-11-treated A549 cells as a physiologically relevant model to investigate the involvement of PtdSer oxidation and its potential mechanism during apoptosis. We demonstrated that ligation of CH-11 with its cognate receptor initiated execution of apoptotic program in interferon gamma-pretreated A549 cells as evidenced by activation of caspase and DNA fragmentation. A significant increase of cytochrome c (cyt c) content in the cytosol as early as 2 h after CH-11 exposure was detected indicating that Fas-induced apoptosis in A549 cells proceeds via extrinsic type II pathway and includes mitochondrial signaling. PtdSer was selectively oxidized 3 h after anti-Fas triggering while two more abundant phospholipids--phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn)--and the major intracellular antioxidant, glutathione, remained nonoxidized. A pan-caspase inhibitor, z-VAD, fully blocked cyt c release and oxidation of PtdSer in Fas-treated A549 cells. On the other hand, z-DQMD, a caspase-3 inhibitor, completely inhibited caspase-3 activity but did not fully block caspase-8 activation and release of cyt c. Importantly, z-DQMD failed to protect PtdSer from oxidation. In addition, in a model system, we demonstrated that peroxidase activity of cyt c was greatly enhanced in the presence of dioleoylphosphatidylserine containing liposomes by monitoring oxidation of 2',7'-dichlorodihydrofluorescein to 2',7'-dichlorofluorescein. We further showed that peroxidase activity of cyt c catalyzed oxidation of 1-palmitoyl-2-arachidonoyl-3-glycero-phosphoserine using a newly developed HPLC assay. MS analysis of 1-palmitoyl-2-arachidonoyl-3-glycero-phosphoserine revealed that in addition to its mono- and dihydroperoxides, several different PtdSer oxidation products can be formed. Overall, we concluded that cyt c acts as a catalyst of PtdSer oxidation during Fas-triggered A549 cell apoptosis.
authors.affiliation: Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
authors.forename: Jianfei
authors.initials: J
authors.lastname: Jiang
authors.forename: Vidisha
authors.initials: V
authors.lastname: Kini
authors.forename: Natalia
authors.initials: N
authors.lastname: Belikova
authors.forename: Behice F
authors.initials: BF
authors.lastname: Serinkan
authors.forename: Grigory G
authors.initials: GG
authors.lastname: Borisenko
authors.forename: Yulia Y
authors.initials: YY
authors.lastname: Tyurina
authors.forename: Vladimir A
authors.initials: VA
authors.lastname: Tyurin
authors.forename: Valerian E
authors.initials: VE
authors.lastname: Kagan
mesh_terms: D000906:Antibodies / Q000276:immunology; D017209:Apoptosis; D053181:Caspase 8; D020169:Caspases / Q000378:metabolism; D002384:Catalysis; D045744:Cell Line, Tumor; D045304:Cytochromes c / Q000378:metabolism*; D004847:Epithelial Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D015227:Lipid Peroxidation; D008168:Lung / Q000166:cytology; D013058:Mass Spectrometry; D010718:Phosphatidylserines / Q000378:metabolism*; D011480:Protease Inhibitors / Q000494:pharmacology; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D000906:Antibodies; D010718:Phosphatidylserines; D011480:Protease Inhibitors; D019014:fas Receptor; D007371:Interferon-gamma; D045304:Cytochromes c; C505530:CASP8 protein, human; D053181:Caspase 8; D020169:Caspases
references.citation: Biochemistry. 1998 May 5;37(18):6402-9
references.pmid: 9572857
references.citation: Blood. 2001 Nov 1;98(9):2603-14
references.pmid: 11675328
references.citation: FEBS Lett. 1999 Nov 26;462(1-2):192-8
references.pmid: 10580118
references.citation: EMBO J. 1983;2(6):907-13
references.pmid: 16453458
references.citation: J Immunol. 2002 Jul 1;169(1):487-99
references.pmid: 12077280
references.citation: Science. 1993 Oct 29;262(5134):689-95
references.pmid: 7901908
references.citation: J Biol Chem. 1986 Mar 15;261(8):3846-56
references.pmid: 3005302
references.citation: Eur Respir J. 2001 Feb;17(2):180-9
references.pmid: 11334117
references.citation: J Neurosci Res. 1998 Feb 1;51(3):293-308
references.pmid: 9486765
references.citation: J Clin Pathol. 2001 Feb;54(2):132-8
references.pmid: 11215282
references.citation: Mol Cell. 2004 May 7;14(3):277-87
references.pmid: 15125832
references.citation: EMBO J. 1998 Mar 16;17(6):1675-87
references.pmid: 9501089
references.citation: Biochemistry. 1997 Oct 21;36(42):13122-32
references.pmid: 9335575
references.citation: Protein Sci. 2000 Jun;9(6):1194-202
references.pmid: 10892811
references.citation: Anal Biochem. 1970 Jul;36(1):225-6
references.pmid: 5482631
references.citation: Am J Physiol. 1997 Feb;272(2 Pt 1):C675-84
references.pmid: 9124312
references.citation: J Invest Dermatol. 2002 Jun;118(6):1008-18
references.pmid: 12060396
references.citation: Am J Physiol. 1998 Dec;275(6 Pt 1):L1192-9
references.pmid: 9843857
references.citation: Biochemistry. 1998 Sep 29;37(39):13781-90
references.pmid: 9753467
references.citation: J Invest Dermatol. 1991 Jul;97(1):115-9
references.pmid: 1647419
references.citation: Transplant Proc. 1997 Feb-Mar;29(1-2):1532-5
references.pmid: 9123414
references.citation: Cell. 1991 Jul 26;66(2):233-43
references.pmid: 1713127
references.citation: Free Radic Biol Med. 2004 Dec 15;37(12):1963-85
references.pmid: 15544916
references.citation: Chem Res Toxicol. 1992 Mar-Apr;5(2):227-31
references.pmid: 1322737
references.citation: Neuron. 1988 Oct;1(8):623-34
references.pmid: 2908446
references.citation: Biochem Biophys Res Commun. 2001 Mar 23;282(1):329-33
references.pmid: 11264011
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11796-800
references.pmid: 8524851
references.citation: Scand J Clin Lab Invest. 1984 Sep;44(5):439-46
references.pmid: 6484484
references.citation: Biochim Biophys Acta. 1996 Sep 4;1283(2):127-40
references.pmid: 8809092
references.citation: Free Radic Biol Med. 2003 Oct 1;35(7):814-25
references.pmid: 14583346
references.citation: J Biol Chem. 1989 Mar 5;264(7):3988-97
references.pmid: 2537300
references.citation: FEBS Lett. 1998 Feb 27;423(3):275-80
references.pmid: 9515723
references.citation: Mol Cell Biochem. 2002 May-Jun;234-235(1-2):125-33
references.pmid: 12162425
references.citation: FEBS Lett. 2000 Jul 14;477(1-2):1-7
references.pmid: 10899301
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: Biochemistry. 1990 Mar 27;29(12):2930-8
references.pmid: 2337575
references.citation: Chem Res Toxicol. 2004 May;17(5):685-96
references.pmid: 15144226
references.citation: Biochem J. 1998 Jan 1;329 ( Pt 1):95-9
references.pmid: 9405280
references.citation: Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):737-44
references.pmid: 11254533
references.citation: Biochemistry. 2002 Feb 12;41(6):2075-88
references.pmid: 11827555
references.citation: Eur Respir J. 1990 Jan;3(1):19-23
references.pmid: 2107097
references.citation: Eur J Biochem. 1992 Oct 1;209(1):267-73
references.pmid: 1396703
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L1-17
references.pmid: 12788785
references.citation: EMBO J. 1997 Aug 1;16(15):4639-49
references.pmid: 9303308
references.citation: Am J Physiol. 1997 Nov;273(5 Pt 1):L921-9
references.pmid: 9374718
references.citation: Methods Mol Biol. 1998;108:71-87
references.pmid: 9921517
references.citation: Nature. 2002 Sep 26;419(6905):367-74
references.pmid: 12353028
references.citation: FEBS Lett. 1998 Mar 27;425(2):209-12
references.pmid: 9559649